Table 2.
Laboratory Findings of the Study Population, Mean Value ± Standard Deviation.
| NCA (n = 55) | CAE (n = 55) | CAD (n = 55) | P Value | |
|---|---|---|---|---|
| WBC (103/μL) | 6.7 ± 1.6 | 6.3 ± 1.8 | 6.7 ± 1.7 | .510 (NS) |
| Hemoglobin (103/μL) | 13.6 ± 1.7 | 13.6 ± 1.5 | 13.4 ± 1.7 | .423 (NS) |
| Platelet (103/μL) | 281 ± 72 | 272 ± 67 | 261 ± 64 | .321 (NS) |
| AST (U/L) | 21.7 ± 8.4 | 23.1 ± 6.1 | 23.5 ± 12.4 | .189 (NS) |
| ALT (U/L) | 22.4 ± 8.2 | 25.3 ± 10.8 | 23.3 ± 21.6 | .966 (NS) |
| TSH (mIU/L) | 1.4 ± 0.9 | 1.7 ± 1.6 | 1.8 ± 1.8 | .915 (NS) |
| FBG (mg/dL) | 111.9 ± 41.9 | 109.6 ± 42.6 | 111.7 ± 40.5 | .819 (NS) |
| HbA1c (%) | 6.1 ± 0.9 | 6.0 ± 0.9 | 6.4 ± 1.7 | .756 (NS) |
| Urea (mg/dL) | 30.0 ± 10.3 | 33.8 ± 17.7 | 33.9 ± 12.9 | .489 (NS) |
| Creatinine (mg/dL) | 0.7 ± 0.1 | 0.8 ± 0.3 | 0.8 ± 0.4 | .476 (NS) |
| Total cholesterol (mg/dL) | 196 ± 44.3 | 199.6 ± 37.8 | 203 ± 45.9 | .672 (NS) |
| LDL-C (mg/dL) | 122.1 ± 34.4 | 123.1 ± 32.9 | 133.5 ± 39.6 | .055 (NS) |
| HDL-C (mg/dL) | 47.6 ± 13.3 | 42.6 ± 8.4 | 44.4 ± 9.8 | .142 (NS) |
| Triglyceride (mg/dL) | 151.7 ± 69.2 | 169.8 ± 84.5 | 161.1 ± 86.4 | .159 (NS) |
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; CAD, coronary artery disease; CAE, coronary artery ectasia; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NCA, normal coronary artery; NS, not significant; TSH, thyroid-stimulating hormone; WBC, white blood cell.